Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and DBT for Suicidality in Treatment-Resistant Depression and Borderline Personality Disorder
NCT07569198Phase 2Recruiting
- Start
- Jul 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in suicidal ideation. Started Jul 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT07569198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07569198.